Bonesupport Holding AB

Bonesupport Holding AB

Health CarePharmaceuticals & Biotechnology
  • Price (SEK)33.00
  • Today's Change0.70 / 2.17%
  • Shares traded18.48k
  • 1 Year change66.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 18 2019 11:26 GMT.
More ▼

Events & Activity

  • BONEX:STO trading volume exceeds daily average by +7,357.57%
  • BONEX:STO price rises above 50-day moving average to 31.80 at 15:02 GMT
  • BONEX:STO price moved over -9.70% to 29.80
  • BONEX:STO price rises above 50-day moving average to 32.00 at 09:02 GMT
  • BONEX:STO price rises above 15-day moving average to 33.30 at 09:13 GMT
  • BONEX:STO price falls below 50-day moving average to 29.80 at 09:03 GMT

Key statistics

As of last trade Bonesupport Holding AB (BONEX:STO) traded at 33.00, -7.04% below its 52-week high of 35.50, set on Jul 04, 2019.
52-week range
17.12Nov 23 201835.50Jul 04 2019
Markit short selling activity
Previous close32.30
Average volume333.94k
Shares outstanding51.95m
Free float44.71m
P/E (TTM)--
Market cap1.68bn SEK
EPS (TTM)-3.23
Data delayed at least 15 minutes, as of Nov 18 2019 11:26 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.